Recombinant Activated Factor VII Administration after Pulmonary Embolectomy: Case Report

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F13%3A10139913" target="_blank" >RIV/00216208:11150/13:10139913 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1532/HSF98.20131026" target="_blank" >http://dx.doi.org/10.1532/HSF98.20131026</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1532/HSF98.20131026" target="_blank" >10.1532/HSF98.20131026</a>

Result language
angličtina
Original language name
Recombinant Activated Factor VII Administration after Pulmonary Embolectomy: Case Report
Original language description
Bleeding management in cardiac surgery could be a great challenge for the surgeon and a life-threatening moment for the patient. Despite the fact that recombinant activated factor VII is now widely accepted as a useful adjunct in the management of postcardiotomy coagulopathy, its use in the course of recent thromboembolic event is rarely described. We hereby present a case of rescue recombinant activated factor VII administration to manage a severe coagulation disorder during surgical pulmonary embolectomy performed under cardiopulmonary bypass.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)